tiprankstipranks
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Compare Alnylam Pharma (ALNY) vs. Competitors

1,405 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$322.11
$42.72B
166.04
42.35%
16 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$96.07
$19.12B
14.98
74.13%
7 Buy
9 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$436.27
$110.83B
29.32
-8.25%
21 Buy
4 Hold
0 Sell
Strong Buy
Argenx Se
$799.65
$49.32B
14.76
46.40%
17 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$28.25
$17.25B
19.86
56.86%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$95.50
$24.00B
-17.95
2.56%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALNY
Alnylam Pharma
322.11
82.10
34.21%
INCY
Incyte
96.07
36.85
62.23%
VRTX
Vertex Pharmaceuticals
436.27
-59.56
-12.01%
ARGX
Argenx Se
799.65
193.26
31.87%
GMAB
Genmab
28.25
8.93
46.22%
BNTX
BioNTech SE
95.50
-6.84
-6.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts